Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Intestinal Neoplasms 2Colonic Neoplasms 2Inflammatory Bowel Diseases 1Colonic Polyps 1

Interventions

Oxaliplatin 3Irinotecan 3Fluorouracil 3Capecitabine 3Bevacizumab 3Leucovorin 2Colonoscopy 2Bisacodyl 2Aspirin 2lutetium Lu 177 dotatate 1guadecitabine 1copper dotatate CU-64 1camrelizumab 1apatinib 1aldesleukin 1XELOX 1Ursodeoxycholic Acid 1Trastuzumab 1Suction 1Simvastatin 1Radiotherapy 1Polyethylene Glycols 1Oviposition 1Lutetium-177 1Lutetium 1Ileostomy 1Folfox protocol 1Drainage 1Cyclophosphamide 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Intestinal Neoplasms × Bisacodyl × Clear all
NCT05032794 2022-12-07

CriLiP

Parc Taulí Hospital Universitari

Phase NA Completed
553 enrolled

Intestinal Neoplasms

NCT01887158 2014-06-17

PEGOP

Ospedale Santa Maria delle Croci

Phase 4 Completed
116 enrolled

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡